Kooman & Associates
- SEC CIK
- 0001961850
- Latest filing
- Jul 22, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Kooman & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,417
- Value
- $859.9K
- % of portfolio
- 0.2%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,417 | $859.9K | 0.2% | +159+4.9% | Added | Holders |
| Q1 2026 | 3,258 | $708.6K | 0.2% | −30−0.9% | Reduced | Holders |
| Q4 2025 | 3,288 | $751.3K | 0.2% | −187−5.4% | Reduced | Holders |
| Q3 2025 | 3,475 | $804.6K | 0.2% | −10.0% | Reduced | Holders |
| Q2 2025 | 3,476 | $645.2K | 0.2% | +40+1.2% | Added | Holders |
| Q1 2025 | 3,436 | $719.9K | 0.3% | +25+0.7% | Added | Holders |
| Q4 2024 | 3,411 | $606.1K | 0.2% | +195+6.1% | Added | Holders |
| Q3 2024 | 3,216 | $635.1K | 0.2% | −14−0.4% | Reduced | Holders |
| Q2 2024 | 3,230 | $554.0K | 0.2% | −16−0.5% | Reduced | Holders |
| Q1 2024 | 3,246 | $591.1K | 0.2% | −132−3.9% | Reduced | Holders |
| Q4 2023 | 3,378 | $523.5K | 0.2% | +36+1.1% | Added | Holders |
| Q3 2023 | 3,342 | $498.2K | 0.3% | +13+0.4% | Added | Holders |
| Q2 2023 | 3,329 | $448.5K | 0.2% | −207−5.9% | Reduced | Holders |
| Q1 2023 | 3,536 | $563.5K | 0.3% | +15+0.4% | Added | Holders |
| Q4 2022 | 3,521 | $569.0K | 0.6% | – | No prior filing | Holders |